Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Fibronectins [Clear All Filters]
Irisin in metabolic diseases..
Endocrine. 59(2), 260-274.
(2018). Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD..
Pulm Pharmacol Ther. 48, 111-116.
(2018).
(2017).
Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease..
Endocrine. 49(2), 560-2.
(2015). Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events..
Int J Obes (Lond). 39(1), 156-61.
(2015). Irisin: A true, circulating hormone..
Metabolism. 64(12), 1611-8.
(2015). An update on the validity of irisin assays and the link between irisin and hepatic metabolism..
Metabolism. 64(9), 937-42.
(2015). Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition..
J Clin Endocrinol Metab. 99(9), 3247-55.
(2014). Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months..
Osteoporos Int. 25(5), 1633-42.
(2014). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2014). Prediction of preterm birth in twins..
Best Pract Res Clin Obstet Gynaecol. 28(2), 265-72.
(2014). Irisin: a renaissance in metabolism?.
Metabolism. 62(8), 1037-44.
(2013).
(2013). Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice..
Am J Respir Cell Mol Biol. 42(6), 753-61.
(2010).